Axsome Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 19X?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders685,1251.41%
General Public985,7702.03%
Hedge Funds4,189,5578.64%
Private Companies7,344,50015.2%
Institutions35,257,42472.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.4%.


Top Shareholders

Top 25 shareholders own 73.92% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.2%
Antecip Capital, L.L.C.
7,344,500€693.5m0%no data
8.64%
RTW Investments, LP
4,189,557€395.6m-9.6%5.47%
8.24%
The Vanguard Group, Inc.
3,995,345€377.2m6.77%0.01%
7.01%
BlackRock, Inc.
3,398,379€320.9m2.98%0.01%
4.87%
Fairmount Funds Management LLC
2,360,077€222.8m0%18.37%
2.24%
FMR LLC
1,087,665€102.7m20.6%0.01%
2.16%
BVF Partners L.P.
1,046,000€98.8m9.53%2.92%
2.06%
RA Capital Management, L.P.
1,000,000€94.4m0%1.15%
2.05%
Macquarie Investment Management Business Trust
995,287€94.0m-7.26%0.11%
1.89%
State Street Global Advisors, Inc.
916,808€86.6m-2.31%no data
1.87%
Geode Capital Management, LLC
908,459€85.8m2.66%0.01%
1.77%
Deep Track Capital, LP
857,219€80.9m-53.7%2.47%
1.71%
Eventide Asset Management, LLC
827,887€78.2m-11.8%1.32%
1.62%
Perceptive Advisors LLC
782,844€73.9m70.5%1.63%
1.53%
Wellington Management Group LLP
742,745€70.1m1.11%0.01%
1.52%
Alethea Capital Management, LLC
738,503€69.7m-0.32%51.7%
1.29%
Hood River Capital Management LLC
625,084€59.0m13.8%0.86%
1.24%
Bank of America Corporation, Asset Management Arm
602,024€56.8m-21.8%0.02%
1.2%
Invesco Ltd.
581,557€54.9m4.68%0.01%
1.19%
Point72 Asset Management, L.P.
577,190€54.5m13.1%0.14%
1.08%
Adage Capital Management, L.P.
525,000€49.6m-28.1%0.09%
0.96%
PFM Health Sciences, LP
467,427€44.1m0%2.86%
0.93%
Mark Coleman
451,866€42.7m2,990%no data
0.83%
Norges Bank Investment Management
404,217€38.2m0%no data
0.83%
Tavistock Life Sciences
400,000€37.8m0%2.44%